90% of the Top 50 Pharma companies rely on Thomson Reuters Pharma™ pipeline intelligence when looking for partners.
Let them know which programs you want to partner.
What the Outpartnering Registry can do for you…
The Outpartnering Registry is a brand new way of letting your organization put information on partnering interest alongside Thomson Reuters Pharma's professionally curated pipeline intelligence. It is available free to all organizations with drugs in development.
The registry allows your authorized users to provide key partnering information about your company and drug pipeline, to be shown directly in Thomson Reuters Partnering. You can:
- Indicate which of your programs and drugs are available for partnering, and, optionally, what type of partnership you are seeking and in which regions of the world
- Add and update the contact details of your Partnering contact(s) together with links to LinkedIn profiles
- Display which Partnering meetings your company will be attending
Benefits for both innovators and those in-licensing...
The Outpartnering Registry will benefit both those innovators and those in-licensing. Innovators will be able to update their partnering information directly, and in-licensors will be able to easily find which assets are available for partnering.
How can I sign up?
The Outpartnering Registry is complimentary to all organizations with drugs in development. Register below to be set up with an account: